Literature DB >> 20824345

Pathophysiology of fatty acid oxidation disorders.

M J Bennett1.   

Abstract

Mitochondrial fatty acid oxidation represents an important pathway for energy generation during periods of increased energy demand such as fasting, febrile illness and muscular exertion. In liver, the primary end products of the pathway are ketone bodies, which are released into the circulation and provide energy to tissues that are not able to oxidize fatty acids such as brain. Other tissues, such as cardiac and skeletal muscle are capable of direct utilization of the fatty acids as sources of energy. This article provides an overview of the pathogenesis of fatty acid oxidation disorders. It describes the different tissue involvement with the disease processes and correlates disease phenotype with the nature of the genetic defect for the known disorders of the pathway.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20824345     DOI: 10.1007/s10545-010-9170-y

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN: 0141-8955            Impact factor:   4.982


  28 in total

1.  Spontaneous development of intestinal and colonic atrophy and inflammation in the carnitine-deficient jvs (OCTN2(-/-)) mice.

Authors:  Prem S Shekhawat; Sonne R Srinivas; Dietrich Matern; Michael J Bennett; Richard Boriack; Varghese George; Hongyan Xu; Puttur D Prasad; Penny Roon; Vadivel Ganapathy
Journal:  Mol Genet Metab       Date:  2007-09-19       Impact factor: 4.797

Review 2.  The mitochondrial carnitine palmitoyltransferase system. From concept to molecular analysis.

Authors:  J D McGarry; N F Brown
Journal:  Eur J Biochem       Date:  1997-02-15

3.  Placental floor infarction complicating the pregnancy of a fetus with long-chain 3-hydroxyacyl-CoA dehydrogenase (LCHAD) deficiency.

Authors:  D Matern; B M Schehata; P Shekhawa; A W Strauss; M J Bennett; P Rinaldo
Journal:  Mol Genet Metab       Date:  2001-03       Impact factor: 4.797

4.  Ophthalmologic findings in long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency caused by the G1528C mutation: a new type of hereditary metabolic chorioretinopathy.

Authors:  T Tyni; T Kivelä; M Lappi; P Summanen; E Nikoskelainen; H Pihko
Journal:  Ophthalmology       Date:  1998-05       Impact factor: 12.079

5.  Hyperinsulinism and hyperammonemia in infants with regulatory mutations of the glutamate dehydrogenase gene.

Authors:  C A Stanley; Y K Lieu; B Y Hsu; A B Burlina; C R Greenberg; N J Hopwood; K Perlman; B H Rich; E Zammarchi; M Poncz
Journal:  N Engl J Med       Date:  1998-05-07       Impact factor: 91.245

6.  A novel brain-expressed protein related to carnitine palmitoyltransferase I.

Authors:  Nigel Price; Feike van der Leij; Vicky Jackson; Clark Corstorphine; Ross Thomson; Annette Sorensen; Victor Zammit
Journal:  Genomics       Date:  2002-10       Impact factor: 5.736

7.  Human placenta metabolizes fatty acids: implications for fetal fatty acid oxidation disorders and maternal liver diseases.

Authors:  Prem Shekhawat; Michael J Bennett; Yoel Sadovsky; D Michael Nelson; Dinesh Rakheja; Arnold W Strauss
Journal:  Am J Physiol Endocrinol Metab       Date:  2003-02-11       Impact factor: 4.310

8.  The paradox of the carnitine palmitoyltransferase type Ia P479L variant in Canadian Aboriginal populations.

Authors:  Cheryl R Greenberg; Louise A Dilling; G Robert Thompson; Lorne E Seargeant; James C Haworth; Susan Phillips; Alicia Chan; Hilary D Vallance; Paula J Waters; Graham Sinclair; Yolanda Lillquist; Ronald J A Wanders; Simon E Olpin
Journal:  Mol Genet Metab       Date:  2009-02-13       Impact factor: 4.797

9.  Mutation and biochemical analysis in carnitine palmitoyltransferase type II (CPT II) deficiency.

Authors:  S E Olpin; A Afifi; S Clark; N J Manning; J R Bonham; A Dalton; J V Leonard; J M Land; B S Andresen; A A Morris; F Muntoni; D Turnbull; M Pourfarzam; S Rahman; R J Pollitt
Journal:  J Inherit Metab Dis       Date:  2003       Impact factor: 4.982

10.  3-Hydroxyacyl-coenzyme A dehydrogenase deficiency and hyperinsulinemic hypoglycemia: characterization of a novel mutation and severe dietary protein sensitivity.

Authors:  Ritika R Kapoor; Chela James; Sarah E Flanagan; Sian Ellard; Simon Eaton; Khalid Hussain
Journal:  J Clin Endocrinol Metab       Date:  2009-05-05       Impact factor: 5.958

View more
  20 in total

Review 1.  Dissociating fatty liver and diabetes.

Authors:  Zheng Sun; Mitchell A Lazar
Journal:  Trends Endocrinol Metab       Date:  2012-10-05       Impact factor: 12.015

2.  High grade glioblastoma is associated with aberrant expression of ZFP57, a protein involved in gene imprinting, and of CPT1A and CPT1C that regulate fatty acid metabolism.

Authors:  Alessandra Cirillo; Anna Di Salle; Orsolina Petillo; Mariarosa A B Melone; Giovanna Grimaldi; Alfredo Bellotti; Giovanni Torelli; Maria Serena De' Santi; Giovanna Cantatore; Alfredo Marinelli; Umberto Galderisi; Gianfranco Peluso
Journal:  Cancer Biol Ther       Date:  2014-03-11       Impact factor: 4.742

3.  Rhabdomyolysis-Associated Mutations in Human LPIN1 Lead to Loss of Phosphatidic Acid Phosphohydrolase Activity.

Authors:  George G Schweitzer; Sara L Collier; Zhouji Chen; James M Eaton; Anne M Connolly; Robert C Bucelli; Alan Pestronk; Thurl E Harris; Brian N Finck
Journal:  JIMD Rep       Date:  2015-05-13

4.  Novel magnetic resonance imaging findings in a patient with short chain acyl CoA dehydrogenase deficiency.

Authors:  Shwetha Chiplunkar; Parayil Sankaran Bindu; Madhu Nagappa; Bobby Baby Panikulam; Hanumanthapura R Arvinda; Periyasamy Govindaraj; M M Srinivas Bharath; Narayanappa Gayathri; J N Jessiena Ponmalar; Pavagada S Mathuranath; Sanjib Sinha; Arun B Taly
Journal:  Metab Brain Dis       Date:  2017-04-03       Impact factor: 3.584

Review 5.  Short-chain acyl-CoA dehydrogenase deficiency: from gene to cell pathology and possible disease mechanisms.

Authors:  Zahra Nochi; Rikke Katrine Jentoft Olsen; Niels Gregersen
Journal:  J Inherit Metab Dis       Date:  2017-05-17       Impact factor: 4.982

6.  Infant with hepatomegaly and hypoglycemia: A setting for fatty acid oxidation defects.

Authors:  Aathira Ravindranath; Gautham Pai; Anshu Srivastava; Ujjal Poddar; Surender Kumar Yachha
Journal:  Indian J Gastroenterol       Date:  2017-10-26

Review 7.  Evaluation of the child with suspected mitochondrial liver disease.

Authors:  Jean P Molleston; Ronald J Sokol; Wikrom Karnsakul; Alexander Miethke; Simon Horslen; John C Magee; René Romero; Robert H Squires; Johan L K Van Hove
Journal:  J Pediatr Gastroenterol Nutr       Date:  2013-09       Impact factor: 2.839

Review 8.  Evidence that Oxidative Disbalance and Mitochondrial Dysfunction are Involved in the Pathophysiology of Fatty Acid Oxidation Disorders.

Authors:  Graziela Schmitt Ribas; Carmen Regla Vargas
Journal:  Cell Mol Neurobiol       Date:  2020-09-02       Impact factor: 5.046

9.  Fatty Acid Oxidation and Cardiovascular Risk during Menopause: A Mitochondrial Connection?

Authors:  Paulo J Oliveira; Rui A Carvalho; Piero Portincasa; Leonilde Bonfrate; Vilma A Sardao
Journal:  J Lipids       Date:  2012-02-01

10.  Fatty acids-stress attenuates gluconeogenesis induction and glucose production in primary hepatocytes.

Authors:  Noga Budick-Harmelin; Sarit Anavi; Zecharia Madar; Oren Tirosh
Journal:  Lipids Health Dis       Date:  2012-07-09       Impact factor: 3.876

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.